Search for content, post, videos

Proposed management changes at Moberg Pharma

Peter Wolpert
The Board of Directors and Nomination Committee have proposed the appointment of Anna Ljung as the new CEO of Moberg Pharma, while current CEO Peter Wolpert will transition to a role as Executive Chairman of the Board of Directors. The divestment of the OTC business on March 29, 2019 represents a
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.